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Abstract
Retroviruses and retrotransposons are vulnerable to a suicidal pathway known as autointegration, which occurs when the
39-ends of the reverse transcript are activated by integrase and then attack sites within the viral DNA. Retroelements have
diverse strategies for suppressing autointegration, but how HIV-1 protects itself from autointegration is not well-
understood. Here we show that knocking down any of the components of the SET complex, an endoplasmic reticulum-
associated complex that contains 3 DNases (the base excision repair endonuclease APE1, 59-39 exonuclease TREX1, and
endonuclease NM23-H1), inhibits HIV-1 and HIV-2/SIV, but not MLV or ASV, infection. Inhibition occurs at a step in the viral
life cycle after reverse transcription but before chromosomal integration. Antibodies to SET complex proteins capture HIV-1
DNA in the cytoplasm, suggesting a direct interaction between the SET complex and the HIV preintegration complex.
Cloning of HIV integration sites in cells with knocked down SET complex components revealed an increase in
autointegration, which was verified using a novel semi-quantitative nested PCR assay to detect autointegrants. When SET
complex proteins are knocked down, autointegration increases 2–3–fold and chromosomal integration correspondingly
decreases ,3-fold. Therefore, the SET complex facilitates HIV-1 infection by preventing suicidal autointegration.
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Introduction
Soon after HIV-1 enters a susceptible target cell, the viral
genomic RNA is reverse transcribed within the reverse transcrip-
tion complex (RTC) to double-stranded DNA [1]. The RTC
matures into the preintegration complex (PIC), which delivers the
viral DNA to the nucleus for integration into a chromosome [2].
The PIC may also sequester and protect the viral DNA from
cellular DNA-modifying enzymes [3] and from cytoplasmic DNA
sensors [4–6] that could trigger antiviral innate immunity.
Surprisingly little is known about the host proteins that associate
with the PIC and assist in HIV-1 integration. Integration can be
divided into three steps: (1) 39 processing (integrase (IN)-mediated
hydrolysis of GT dinucleotides from HIV-1 DNA to produce
reactive, recessed CAOH-39 ends); (2) DNA strand transfer (IN-
mediated insertion of the cleaved 39 ends into opposing strands of
host chromosomal DNA); and (3) 59-end joining (repair by host
enzymes of the gaps between the 59-ends of viral DNA and the
chromosome) [7].
39-processing makes the viral DNA vulnerable to autointegra-
tion [8,9] in which the reactive CA ends attack sites within the
viral DNA. Autointegration is mechanistically analogous to
chromosomal integration, but results in nonproductive deletion
or inversion circles [9–12]. Autointegration is a problem faced not
only by retroviruses, but also by mobile genetic elements including
bacteriophages and retrotransposons [10,13,14]. Each element
employs a unique mechanism, relying on either self or host factors,
to control autointegration. For example, bacteriophage Mu B
protein activates DNA strand transfer to favor intermolecular
transposition [14,15]. In the case of Tn10, a cellular global
regulator, H-NS, acts directly on the PIC to promote intermolec-
ular transposition [16]. The barrier-to-autointegration factor
(BAF) is a cellular protein that protects Moloney murine leukemia
virus (MLV) PICs from autointegration and stimulates intermo-
lecular integration in vitro [12,17]. Although BAF can also
stimulate HIV-1 PIC intermolecular integration activity in vitro, it
has not been shown to block HIV-1 autointegration [18–20].
39-processing can occur soon after the DNA ends are
synthesized by reverse transcription in the cytoplasm [21],
suggesting that a cytoplasmic mechanism might be needed to
protect HIV-1 from autointegration. We therefore considered host
cytosolic DNA-interacting proteins as potential regulators of
autointegration. One candidate is the SET complex, an endo-
plasmic reticulum (ER)-associated DNA repair complex that
contains three DNases and is mobilized to the nucleus in response
to oxidative stress. The SET complex was discovered as a
Granzyme A (GzmA) target in cells undergoing caspase-indepen-
dent T cell-mediated death [22]. Two nucleases in the complex,
the endonuclease NM23-H1 and the exonuclease TREX1, are
activated by GzmA cleavage of the inhibitor SET protein to cause
single-stranded DNA damage [23,24]. In addition to the three
DNases (APE1, NM23-H1, TREX1) and SET (a histone
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complex contains HMGB2, a DNA binding protein that
preferentially binds to distorted or damaged DNA, and the
PP2A inhibitor pp32 [25]. Although individual SET complex
components have been implicated in diverse processes (including
DNA repair, histone modification, DNA replication, transcrip-
tional activation, single-stranded DNA degradation, autoimmuni-
ty), the functions of the intact complex are not well understood
[26]. Here we show that the SET complex plays an important role
in the early phase of the HIV-1 lifecycle by inhibiting
autointegration.
Results
Silencing SET complex proteins inhibits HIV-1 infection
Knockdown of SET and/or NM23-H1 in HeLaCD4 cells
reduced HIV-1IIIB infectivity 3 to 4-fold as assessed by p24 levels
in culture supernatants (Figure 1A). Although viral replication was
impaired, the virions produced from knockdown cells were equally
infectious when applied in equivalent amounts (normalized by p24
level) to indicator TZM-bl cells that express an HIV LTR-driven
luciferase (Luc) reporter gene (Figure S1). This suggested that SET
and NM23-H1 act early in the viral life cycle. To focus on early
events, cells were infected with an HIV-1-derived single-round
reporter virus (HIV-Luc) pseudotyped with the vesicular stomatitis
virus G (VSV-G) envelope glycoprotein [18], and infection was
assessed two days later by Luc activity. Knockdown of SET,
NM23-H1, or both reduced Luc activity to 24%, 19%, and 15%
of control levels, respectively (Figure 1B). HIV-Luc activity was
restored by expressing RNAi-insensitive SET (SET-in) in SET
siRNA-treated cells (Figure 1C). SET knockdown and SET-in
rescue had similar effects when infections were performed using a
range of multiplicities of infection (MOI) (Figure S2). Single-round
virus carrying the natural HIV-1 envelope glycoprotein was
similarly inhibited by SET and/or NM23-H1 knockdown (data
not shown).
Because inhibition was independent of the envelope glycopro-
tein, SET and NM23-H1 likely influenced post-entry steps. SET
can influence chromatin accessibility in its role as a histone
chaperone and inhibitor of histone acetylation and DNA
demethylation, and NM23-H1 enhances the transcription of some
genes [26,27]. We therefore tested whether knocking down SET
and NM23-H1 inhibited transcription from transfected HIV-Luc
plasmid DNA and from a chromatinized reporter gene. There was
no significant effect on expression from transfected HIV-Luc and
only a weak effect (,25%, p,0.05) on Tat-dependent expression
from the chromatinized reporter gene (Figure 1D and 1E).
Together these experiments suggest that SET and NM23-H1 act
primarily downstream of viral entry and before Tat-dependent
transcription.
The SET protein is a component of at least two complexes – a
,150 kDa nuclear complex that contains SET and pp32 and
some of their paralogues and the ,270–420 kDa ER-associated
SET complex [22,28]. Because NM23-H1 knockdown interfered
with HIV-1, we reasoned that the larger SET complex facilitated
infection. In fact, knocking down two other members of this
complex, APE and TREX1, similarly reduced HIV-Luc activity
(Figure 2).
To test whether SET complex proteins enhance infection of
other retroviruses, the effect of knocking down SET complex
proteins on MLV and avian sarcoma virus (ASV) was tested using
similar Luc reporter systems. Both MLV-Luc and ASV-Luc were
largely unaffected when SET complex proteins were knocked
down (Figure 2A and 2B). By contrast, the infectivity of two other
lentiviruses, SIV-Luc and HIV-2, was reduced approximately two-
fold by SET/NM23-H1 knockdown (Figure 2C and 2D). These
results suggest that the SET complex specifically affects lentiviral
infection.
SET/NM23-H1 knockdown reduces chromosomal
integration
To pinpoint the block in the viral life cycle, we compared the
effect of SET/NM23-H1 knockdown on stage-specific HIV-1
DNA products by quantitative PCR (qPCR) [29,30]. Late reverse
transcription products (late RT) measured during the first day of
infection were not significantly different in knockdown cells
(Figure 3A). In contrast, integrated HIV-1 DNA (quantified by
nested Alu-PCR) was reduced by 3-fold 24 h post infection (hpi) in
SET/NM23-H1 knockdown cells (Figure 3B). Two-long terminal
repeat (2-LTR) circles were slightly (about 28%, p.0.05)
increased by the knockdown (Figure 3C).
To understand why HIV-1 integration might be impaired,
insertion sites were sequenced [29] using DNA isolated 24 hpi
from control and SET/NM23-H1 knockdown cells. HIV-1
normally integrates preferentially into transcriptionally active
chromatin [31,32]. The frequency of integration within transcrip-
tion units, CpG islands, and promoters was not significantly
different in the knockdown cells (Table 1). Although the DNA for
the integration site analysis was isolated from the Hirt pellet, which
is enriched for chromosomal DNA, a significant number of clones
arose from autointegration. The proportion of autointegrants
recovered from SET/NM23-H1 knockdown cells exceeded the
control, comprising 259 of 816 (32%) vs 182 of 816 (22%)
sequences (p,0.0001) (Table 1, Figure 4). The autointegration
sites in the control and knockdown cells showed the same sequence
preference as chromosomal integration, favoring insertion within
GG dinucleotides (Figure S3) [29,33].
SET/NM23-H1 knockdown enhances autointegration
Because there are no assays to quantify HIV-1 autointegration,
a nested qPCR autointegration assay (auto-PCR) was designed to
quantify and clone autointegration events from Hirt supernatant
DNA. Three primers (PBS2 (primer binding site), A+, and B2)
were designed to detect integration of the minus strand U3 CA-39
end into either strand of viral DNA (Figures 5A and S4). The first
PCR round generates products that contain the upstream LTR
and internal viral sequences of variable length depending on the
distance between the site of autointegration and primer A+ or B2.
The qPCR (second) round amplifies LTR sequences of a fixed
length from diluted first-round PCR products. To validate the
assay, we verified that first-round PCR using only PBS or A+ and
B2 primers amplified negligible amounts of LTR-containing
DNA compared to reactions with all 3 primers. Autointegration is
expected to occur shortly after reverse transcription because 39
Author Summary
When HIV-1 infects a cell, its genomic RNA is copied into
DNA. The ends of the viral DNA are then activated by the
viral integrase enzyme to enable DNA insertion into a host
cell chromosome. However, the activated ends can
alternately insert into the virus itself by a process called
autointegration, which is a suicidal pathway that aborts
the infection. How HIV-1 protects itself from suicidal
autointegration is not known. Here we show that a
cytoplasmic complex, called the SET complex, which
contains three DNA digesting enzymes, binds to HIV-1
and protects it from autointegration.
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and late RT DNAs both peaked 10 hpi, while 2-LTR circles and
integrated DNA peaked 24 hpi (Figure 5B). These kinetics support
the specificity of the auto-PCR assay to detect autointegrants
rather than 2-LTR circles. Consistent with the hypothesis that
most autointegration events likely arise from the concerted
insertion of both U3 and U5 viral DNA ends [34], the kinetics
of U5 end joining closely mirrored those of U3 (Figure S5). Since
autointegration requires IN activity, HeLaCD4 cells were infected
with HIV-Luc carrying either wild-type (WT) or active site mutant
(D64N/D116N, mt) IN. As expected, auto-PCR product forma-
tion was significantly reduced following mt IN viral infection
(Figure 5D). First-round PCR products analyzed by electropho-
resis through agarose gels produced a smear migrating at ,1k b
Figure 1. The SET complex facilitates HIV-1 infection. (A) SET and/or NM23-H1 knockdown inhibits HIV-1IIIB infection. HeLaCD4 cells
transfected with a non-targeting control siRNA (CTL) or siRNAs targeting SET and/or NM23-H1 were infected with HIV-1IIIB, and infection was assayed
by p24 release. (B) SET and/or NM23-H1 knockdown blocks single-round HIV-Luc infection. HeLaCD4 cells were transfected with indicated siRNAs and
infected with VSV-G pseudotyped HIV-Luc. Luciferase (Luc) activity, measured 48 hpi and normalized to total cellular protein, is compared to Luc
activity in cells transfected with control siRNA. (C) Expression of siRNA-insensitive SET (SET-in) rescues the HIV-Luc infection block caused by knocking
down endogenous SET. 293T cells, transfected with control or SET siRNAs and then transfected two days later with empty vector or SET-in and pCMV-
b-gal plasmids, were infected with HIV-Luc 24 h after transfection, and Luc activity measured 48 h later was normalized to b-galactosidase activity. (D)
Expression from transfected HIV-Luc DNA is not affected by SET/NM23-H1 knockdown. HeLaCD4 cells were transfected with HIV-Luc plasmid two
days following siRNA transfection. Luc activity was measured 24 h later and normalized as in (D). (E) Expression from a chromatinized HIV-Luc
reporter gene is weakly affected by SET/NM23-H1 knockdown. TZM-bl cells that harbor an integrated LTR-Luc reporter gene were first transfected
with control or SET/NM23-H1 siRNA, and then transfected 48 h later with either an empty vector or a Tat expression plasmid to activate reporter gene
expression. Luc activity was measured 24 h later. (F) Immunoblots showing SET/NM23-H1 knockdown and SET-in over-expression. SET-in is an siRNA-
insensitive FLAG-HA-tagged protein. *, p,0.001 relative to control knockdown in (A) and (B). **, p,0.05 relative to control in (E). Mean and standard
deviation (S.D.) from at least four independent infections are shown in (A–E).
doi:10.1371/journal.ppat.1000327.g001
Figure 2. Knockdown of SET complex proteins inhibits HIV-1 and HIV-2/SIV, but not MLV or ASV infection. (A) Knockdown of SET/
NM23-H1, APE1, or TREX1 inhibits HIV-Luc, but not MLV or ASV single-round reporter viruses. Luc activity was measured 48 hpi. (B) Immunoblot
confirms APE1 knockdown. TREX1 knockdown, assayed by qRT-PCR, reduced TREX1 mRNA by 94% (not shown). (C,D) Knockdown of SET/NM23-H1
also inhibits SIV-Luc (C) and HIV-2 (D) infection. *, p,0.01. **, p,0.05.
doi:10.1371/journal.ppat.1000327.g002
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appreciable DNA in this region (Figure 5E). The 1 kb smear is
likely the consequence of the 3 min extension time used in the first
round PCR (see Materials and Methods). DNA from the regions
corresponding to the 1 kb smear were isolated, cloned, and
sequenced. 21 of 30 clones from the WT viral infection contained
an IN-processed U3 end (identified by loss of the GT dinucleotide
from the unprocessed CAGT strand). The processed U3 end
joined to an internal viral sequence in 13 cases, whereas the
remaining 8 sequences contained only viral LTR sequences (Table
S1). Only 5 of 30 clones from the mt IN virus infection contained
any viral sequence, and none contained a processed U3 end (Table
S1). The mt virus likely supported low level auto-PCR product
formation (Figure 5D) due to background amplification of
nonspecific first round PCR products (Figure 5E, Table 1) and/
or increased levels of unintegrated DNA that form under these
infection conditions [35]. These results demonstrate that the auto-
PCR assay predominantly amplifies autointegrated HIV-1 DNA.
With the auto-PCR assay validated, we compared autointegra-
tion and other stage-specific HIV-1 DNAs in control and SET/
NM23-H1 knockdown cells (Figure 6A). Late RT products were
comparable 10 hpi as shown in Figure 3A, whereas autointegra-
tion assayed at the same time increased 2.5 fold in SET/NM23-
H1 knockdown cells (p,0.01). Chromosomal integration mea-
Figure 3. HIV-1 integration is reduced in SET/NM23-H1 knockdown cells. (A–C) Late RT products (normalized to mitochondrial DNA) (A) and
integrated DNA (normalized to b-globin sequences) (B), measured at indicated times, and 2-LTR circles, measured 24 hpi (C), from control (black) or
SET/NM23-H1 (gray) knockdown cells. Data are mean+/2S.D. of triplicate measurements from three independent experiments, normalized to control
knockdown cells. *, p,0.001.
doi:10.1371/journal.ppat.1000327.g003
Table 1. Increased number of HIV autointegration events recovered from SET/NM23-H1 knockdown cells.
Control Knockdown Library SET+NM23-H1 Knockdown Library
p-Value (Comparing Two
Libraries)
Number of
Sequences
% of Total Unique
Integration Sites
Number of
Sequences
% of Total Unique
Integration Sites
Total 816 816
Passed initial parsing 680 623
Autointegrants 182 259 ,0.001
Mapped to genome 294 232
Unique sites 239 100% 172 100%
mRNA 204 85.4% 147 85.5%
Ensembl 198 82.8% 137 79.7%
Refseq 190 79.5% 132 76.7% .0.5
CpG-1kb 3 1.3% 0 0%
CpG-2kb 25 10.5% 11 6.4% .0.1
CpG-5kb 59 24.7% 40 23.3%
Refseq-2.5kb 18 7.5% 10 5.8% .0.6
Refseq-5kb 38 15.9% 29 16.9%
SET/NM23-H1 knockdown does not affect chromosomal integration site preferences, but enhances autointegration. DNA was cloned and sequenced from the Hirt
pellet.
Gene IDs for the genes mentioned in the text are: SET 6418, NM23-H1 4830, APE1 328, TREX1 11277, PP2A 5515, PP32 8125, HMGB2 3148, LEDGF 11168, BAF 8815, and
APOBEC3G 60489.
doi:10.1371/journal.ppat.1000327.t001
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NM23-H1 knockdown as compared to control cells (Figure 6A).
The corresponding increase in autointegration and decrease in
chromosomalintegrationsuggested thattheintegrationdefectisdue
to reduced available substrate because of suicidal autointegration.
Because increased autointegration occurred before chromosom-
al integration, it was unlikely that autointegration was secondary to
failed chromosomal integration. To test directly whether auto-
integration might be an obligate side product of failed integration,
we quantified autointegration events in ledgf
2/2 and ledgf
+/+ mouse
embryo fibroblasts (MEF) infected with HIV-Luc. LEDGF is a
nuclear factor, which tethers the PIC to genomic DNA and plays a
crucial role in chromosomal integration [29,36,37]. Although
HIV-Luc infection of ledgf
2/2 cells was barely detectable
compared to ledgf
+/+ MEF, autointegration did not significantly
change in ledgf
2/2 MEF (the IN within the PIC is fully active in
ledgf
2/2 cells [29]) (Figure 6B). Therefore autointegration is not an
obligate side effect of decreased chromosomal DNA integration.
LEDGF and the SET complex did not coimmunoprecipitate in
infected cells and recombinant IN and SET also did not
coprecipitate (data not shown). Our results collectively indicate
that the SET complex suppresses autointegration rather than
augments chromosomal integration. In support of this, individual
knockdown of TREX1 or APE1, two other SET complex
components, also significantly increased autointegration
(Figure 6C). Just as NM23-H1 knockdown enhanced autointegra-
tion, overexpressing NM23-H1 in an NM23-H1 defective human
breast cancer cell line (MDA-MB-435) suppressed HIV-1 auto-
integration by 2-fold (p,0.001) but had no effect on reverse
transcription (Figure 6D).
BAF can augment HIV-1 integration in vitro [20] and in cells
[19], although its overall importance during virus infection is
controversial [18,19]. To determine whether BAF regulates
autointegration, lysates prepared from HIV-Luc-infected control
and BAF knockdown cells were assayed by auto-PCR. BAF
knockdown was efficient (92% protein knockdown) and reduced
Luc activity about 2-fold (Figure S6A and S6B), but had no effect
on autointegration (Figure S6C). Although we cannot exclude a
role for BAF in regulating autointegration, its knockdown reduced
HIV-1 infection ,2-fold without a concomitant change in auto-
PCR product formation. We therefore conclude that suppression
of autointegration is unlikely to be the dominant mechanism
through which BAF regulates HIV-1 infection.
SET and NM23-H1 associate with HIV-1 DNA in the
cytoplasm
Autointegration product formation peaked in parallel with the
late RT product (Figure 5B), suggesting that autointegration
occurs in the cytoplasm. In fact, 68% of autointegrants at their
peak 10 hpi were in cytoplasmic rather than nuclear lysates (data
not shown). We therefore predicted that the SET complex would
associate with HIV-1 reverse transcripts in the cytoplasm. The
ability of SET complex and control antibodies to capture HIV-1
cDNA from cytoplasmic lysates 6 hpi was analyzed (Figure 6E). IN
and matrix (MA) antibodies captured 7.7% and 4.3% of
cytoplasmic HIV-1 DNA, respectively, as assessed by qPCR.
LEDGF antibody did not pull down a significant amount of HIV-
1 DNA, in contrast to a previous report [38]. SET and NM23-H1
antibodies, which immunoprecipitated ,30–40% of these abun-
dant proteins from input samples (data not shown), pulled down
2.4% and 3.1% of HIV-1 DNA, respectively, significantly more
than rabbit IgG control (p,0.005 and p,0.001, respectively). The
direct association of SET complex proteins with HIV-1 DNA in
the cytoplasm early in infection further supports its role in
preventing autointegration.
Figure 4. Autointegration sites recovered from control and SET/NM23-H1 knockdown libraries. Each site within selected 1.5-kb regions
of the HIV-1 genome (numbering based on the HIV-1NL4-3 strain) is represented as a dot. Autointegrants from control siRNA-treated and SET/NM23-
H1 knockdown cells are black and red, respectively.
doi:10.1371/journal.ppat.1000327.g004
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PLoS Pathogens | www.plospathogens.org 5 March 2009 | Volume 5 | Issue 3 | e1000327Figure 5. A PCR-based assay for measuring HIV autointegration (auto-PCR). (A) Diagram of HIV-1 auto-PCR assay (a more detailed diagram
is provided in Figure S4). The common primer binding site (PBS2) (reverse) primer is used to amplify same strand integrants with the A+ (forward)
primer or opposite strand integrants with the B2 (reverse) primer during first-round PCR. A single-length nested PCR product is then amplified using
an LTR primer pair (R-U5) during second-round qPCR. Filled circles, internal viral 59 phosphates attacked during autointegration. (B) Kinetics of stage-
specific HIV-1 DNA product formation. Late RT, autointegrants, and 2-LTR circles were normalized to mitrochondrial DNA; integrated DNA was
The SET Complex Inhibits HIV-1 Autointegration
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Since our previous studies were performed in HeLaCD4 cells,
we wanted to verify the postulated role for the SET complex in
more physiologically relevant T cells. We produced Jurkat cells
stably knocked down for APE1 by infection with a lentivirus
expressing a shRNA targeting APE1 (sh-APE1). Knocking down
APE1 did not alter cell viability or proliferation (data not shown).
APE1 knockdown cells infected with HIVIIIB had significantly
reduced levels of integrated HIV DNA and viral production
compared to cells expressing the sh-CTL control hairpin
(Figure 7A and 7B), suggesting that APE1 also facilitates HIV-1
infection in immune system cells. SIV-Luc infection was also
strongly inhibited (,10-fold) in Jurkat cells by APE1 knockdown,
but MLV-Luc infection was not significantly inhibited (p.0.05)
(Figure 7C). These results confirm the lentiviral specificity of the
SET complex.
Discussion
Our results identify the SET complex as a cytoplasmic barrier to
autointegration. Knockdown of 4 SET complex proteins increased
autointegration and decreased chromosomal integration. Knock-
down of individual SET complex components reduced HIV
infection between 3 and 10 fold and increased autointegration
approximately 2–3 fold. Moreover, the SET complex proteins
SET and NM23-H1 associate with HIV-1 DNA in the cytoplasm.
Although there are reports that other DNA repair factors either
facilitate or inhibit HIV-1 infection, most of these have been
postulated to influence 2-LTR circle formation or 59 gap repair
and to act at a later stage of infection in the nucleus [3,39–43].
A new assay was developed in this study to measure
autointegration. Our results verified that HIV autointegration is
IN-dependent and that it occurs around the time of reverse
transcription. Autointegrants accumulate preferentially in the
cytoplasm, suggesting that most autointegration occurs before
PIC nuclear import. The auto-PCR assay is semi-quantitative,
since the first step involves conventional PCR. Therefore we were
unable to use it to quantify the level of autointegration products
during HIV infection in comparison to other HIV DNAs, e.g. late
RT and 2-LTR circles. We and others [11,20] have been unable
to detect autointegration products by Southern blot using
biochemically fractionated PICs in an in vitro assay. HIV infection
is relatively inefficient and only autointegration products arising
from opposite-strand joining yield a product of discrete size (Figure
S4). The frequency of opposite- versus same-strand joining is
about 1 to 9 (data not shown), possibly contributing to the
difficulty in identifying autointegration products by Southern blot.
The reduction in HIV replication caused by knocking down
SET complex genes is lower than the typical log changes seen by
inhibiting key viral enzymes, such as reverse transcriptase or IN.
This difference is not unexpected, given the postulated role of the
SET complex in preventing a suicidal side pathway rather than as
an essential host factor in executing viral replication. Moreover,
since knockdown is incomplete, the effect we measured might be
dampened by the function of the remaining unknocked down
protein. This problem could be exacerbated by the fact that the
SET complex is very abundant in cells and not much protein
would be expected to interact with a single PIC. The observed
increase in autointegration and corresponding decrease in
chromosomal integration, measured by the auto-PCR and Alu-
PCR assays, respectively, were less than the reduction in viral
replication as measured by Luc assay or p24 production. These
quantitative differences may be due to different sensitivities of the
semi-quantitative PCR-based assays as compared to the Luc and
p24 assays.
In addition to its role in preventing autointegration, the SET
complex might affect other steps in the viral life cycle. For
example, SET complex proteins are known to regulate transcrip-
tion [26,27] and a slight, but significant, reduction in transcription
from a chromatinized HIV reporter gene was observed in SET/
NM23-H1 knockdown cells. SET can act as a histone H2B
chaperone to either assemble or disassemble nucleosomes, thereby
altering accessibility for transcription, and together with pp32 can
regulate histone modifications. Moreover, SET, pp32 and NM23-
H1 can enhance transcription from some promoters [26,27].
The SET complex contains 3 DNases - the base excision repair
(BER) apurinic endonuclease APE1, a DNA nicking endonuclease
NM23-H1, and a 59-39 exonuclease TREX1, which may serve as
a BER proofreading endonuclease [44]. Our preliminary data
suggest that the presumed BER function of the SET complex,
which has not formally been demonstrated, is involved in its role in
blocking HIV-1 autointegration (data not shown). Although APE1
nicking has previously been proposed as a threat to HIV-1 cDNA
[45], our results suggest that within the SET complex, APE1 plays
a protective role. One of the roles of BER is to repair
misincorporated deoxyuridine in DNA that occurs by utilizing
dUTP in place of dTTP or by spontaneous deamination of
incorporated cytosines, which is enhanced under oxidative
conditions. For HIV-1 this represents a particular problem
because reverse transcriptase (RT) does not effectively distinguish
dUTP from dTTP and the dUTP/dTTP ratio is especially high in
primary immune cells susceptible to HIV-1 infection [46].
Moreover, the host cytidine deaminase APOBEC3G (A3G) can
attack the minus strand during reverse transcription in immune
cells [47,48] and introduces dC-to-dU changes that can be
repaired by BER. Although most of our results were obtained in
A3G2 HeLaCD4 cells, we also showed that the SET complex
facilitates HIV replication and integration in A3G+ Jurkat T cells.
In addition to its nuclease function, NM23-H1 is a nucleoside
diphosphate kinase that catalyzes the exchange of dNDPs for
dNTPs and therefore potentially regulates the pool of nucleotides
available for reverse transcription and/or repair.
HIV autointegration generates defective DNA products includ-
ing nicked inverted and subgenomic dsDNA circles ([34] and
Figure S4). The presence of these DNAs in the cytoplasm can
potentially be recognized by cytosolic DNA sensors and trigger the
interferon (IFN)-stimulatory DNA (ISD) response [5,49]. One of
the SET complex proteins, TREX1, has recently been identified
as a negative regulator of the ISD response [6]. TREX1 is the
major 59-39 DNA exonuclease in mammalian cells, and mutations
in the human TREX1 gene are associated with Aicardi-Goutieres
syndrome (AGS), lupus syndromes and other pro-inflammatory
autoimmune diseases [50–53]. TREX1 deficient cells accumulate
cytoplasmic DNA derived from endogenous retroelements [6],
which can then activate IRF3 to trigger production of type I IFNs
leading to autoimmunity. Endogenous retroelements share many
normalized to b-globin. Values of late RT and autointegration are shown relative to peak values 10 hpi, while 2-LTR and integrated DNA are
normalized to peak 24 hpi values. Mean and S.D. from triplicate qPCR measurements are shown. (C–E) Active IN is required for autointegration.
HeLaCD4 cells were infected with HIV-Luc carrying wild type (WT) or mutant (mt) IN. Luc activity was measured 48 hpi (C) and auto-PCR was
performed 10 hpi (D). First-round PCR products (E) from Hirt supernatant DNA were analyzed by agarose gel electrophoresis.
doi:10.1371/journal.ppat.1000327.g005
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PLoS Pathogens | www.plospathogens.org 7 March 2009 | Volume 5 | Issue 3 | e1000327Figure 6. The SET complex suppresses HIV-1 autointegration. (A) Stage specific HIV-1 DNAs from control and SET/NM23-H1 knockdown cells
infected with HIV-Luc. Late RT (LRT) and autointegration were measured 10 hpi and chromosomal integration was assayed 24 hpi. Mean and S.D.
from triplicate qPCR assays of three independent experiments are shown. *, p,0.01. (B) Autointegration is not an obligate by-product of failed
integration. Autointegration was measured 10 hpi and Luc activity at 48 hpi. The difference in autointegration is not significant. (C) Knocking down
other SET complex proteins, TREX1 or APE1, also increases autointegration. Mean plus S.D. from two independent experiments are shown. *, p,0.01.
(D) NM23-H1 over-expression suppresses autointegration. MDA-MB-435, an NM23-H1–deficient metastatic breast cancer cell line, stably transfected
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tion and chromosomal integration. Retroelements can also
undergo autointegration [10]. In this study, TREX1 knockdown
inhibited HIV infection 10-fold, representing the strongest effect of
any of the SET components tested (Figure 2A). By both reducing
autointegration and digesting DNA products produced during the
autointegration events that do occur, TREX1 may further
promote HIV infection by inhibiting the secretion of Type I
IFNs, key effectors of antiviral innate immunity.
We are intrigued by the possibility that HIV nucleic acids may
engage similar cell-intrinsic factors as endogenous retroelements.
One example of such a factor is A3G, which was identified
through its ability to mutate the genome and inhibit HIV infection
[48,54,55]. APOBEC3 proteins also inhibit Alu and LINE-1
retrotransposition, by potentially sequestering retrotransposon
RNAs in high-molecular-weight complexes [54,56].
Understanding how the SET complex binds to the HIV PIC and
regulates lentiviral autointegration requires further study. Viral DNA
in the PIC is accessible to exogenously introduced endonucleases
[21,57,58],soadirectinteractionbetweenSETcomplexproteinsand
HIV-1 DNAis plausible. We do not know whether the SETcomplex
remains associated with the PIC during and after nuclear import.
Since theSET complexshuttlesback andforthto the nucleus[22,26],
this remains a distinct possibility. The mechanism used by the SET
complex to inhibit lentiviral autointegration may provide insight into
how to inhibit viral replication by inducing autointegration. Small
molecule drugs that inhibit SET complex function or change its
cellular distribution could be explored for antiviral therapy.
with vector (C-100) or an NM23-H1 expression plasmid (H1-117), were infected with VSV-G pseudotyped HIV-Luc, and LRT and autointegrants were
measured 10 hpi. *, p,0.01. (E) SET and NM23-H1 associate with HIV-1 cDNA. Cytoplasmic extracts from infected HeLaCD4 cells were
immunoprecipitated with the indicated antibodies (mouse (m) or rabbit (rab)), and associated HIV-1 cDNA was quantified by qPCR. Mean plus S.D.
from three independent experiments are shown.
doi:10.1371/journal.ppat.1000327.g006
Figure 7. APE1 enhances HIV infection in Jurkat T cells. Jurkat cells expressing sh-CTL or sh-APE1 were infected with HIVIIIB, and integrated
DNA (A) and p24 release into the medium (B) were measured at indicated times. Mean plus S.D. from two independent experiments are shown. (C)
APE1 knockdown in Jurkat cells inhibits HIV-Luc and SIV-Luc, but not MLV-Luc, infectivity. (D) Immunoblot showing APE1 knockdown in sh-APE1
lentivirus-infected Jurkat cells.
doi:10.1371/journal.ppat.1000327.g007
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Cell lines
Cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco) supplemented with 10% heat-inactivated fetal
bovine serum (FBS) at 37uC and 5% CO2 unless specified
otherwise. HeLaCD4 and TZM-bl cells were obtained form the
NIH AIDS Research and Reference Reagent Program. Jurkat
cells, obtained from ATCC, were maintained in RPMI medium
supplemented with 10% FBS. MDA-MB-435 cell lines, C100 and
H1-117 were a kind gift of Patricia Steeg (NCI) [59]. Chicken DF1
cells (a gift of James Cunningham, Harvard Medical School) were
propagated in DMEM/10% FBS, 100 U/mL penicillin G
sodium, and 100 mg/mL streptomycin sulfate. The ledgf
+/+ and
ledgf
2/2 MEF used in this study are described as E17(+/+) and
E16(2/2), respectively, in [60].
Virus production and infection
HIVIIIB was propagated as described previously [61]. HIV-2
strain MLP-15132 was obtained from the NIH AIDS Research and
Reference Reagent Program (contributed by Lutz Gu ¨rtler and
Friedrich Deinhardt). HIV-2 infectivity was measured by FACS
staining with p24-FITC antibody (BD Biosciences) 24 hpi. HIV-
Luc and MLV-Luc constructs were described previously [18]. SIV-
Luc was kindly provided by Nathaniel Landau (NYU). Viral
supernatants were produced from transfected 293T cells as
described [18]. ASV-Luc (24 mL) was produced from DF1 cells
plated at 2610
6/10 cm dish the day prior to co-transfecting with
15 mg pRIAS-Luc and 10 mg pHCMV-G [62] using Fugene 6 as
recommended by the manufacturer. Virus was harvested over 3
successive days and concentrated approximately 32-fold by
ultracentrifugation prior to use. HIV-1 was titered by p24 ELISA,
and infections were performed for 6–8 h at an MOI of 1 before
replacing viral supernatants with fresh medium. Luc activity was
assayed 48 hpi as described [18]. Briefly, cells in 12-well plates were
lysed with 250 uL 16Passive Lysis Buffer (Promega) for 15 min at
room temperature. Cell lysates were collected as supernatants after
a quick spin to pellet cell debris. Luc activity was measured using
Luc Assay Reagent (Promega) substrate ina Synergy2 luminometer
(BioTek). Protein levels in cell lysates were determined by BCA
assay (Thermo Scientific). b-galactosidase activity was measured
using Gal Screen (TROPIX). shRNA containing lentiviruses were
generated by co-transfecting 293T cells with three plasmids,
pLentiLox-shRNA [63], pHRgagpol and pVSVG (4:4:2 ratio),
and viral supernatants were collected 48 h post transfection. Jurkat
celllines expressing shRNAsweregeneratedby infectionwith VSV-
G-pseudotyped lentivirus containing sh-CTL or sh-APE1 and
sorting for GFP expressing cells 2 d later. These cells were
subsequently challenged with single-round reporter viruses to test
the role of APE1 in T cell infection. All Jurkat cell infections were
done by spinoculation at 1500 g for 2 h.
For experiments that measured stage-specific HIV-1 DNAs,
viral supernatants were pretreated with 40 U/mL Turbo DNase
(Ambion) at 37uC for 1 hr. Cells were infected using DNase-
treated viruses, and DNA was isolated using the Hirt method [64]
at specified times post infection.
Plasmids, siRNAs, transfection
SET cDNA was PCR amplified from pET26b-SET [22] using
primers containing BamHI and XhoI restriction sites and a FLAG-
HA dual-tag on the C-terminal end (DYKDDDDKQQYPYDVP-
DYA, FLAG-QQ-HA). The resultant fragment was subsequently
cloned into pcDNA3 (Invitrogen) to generate pcDNA-SET-
FLAG-HA for expression in mammalian cells. pcDNA-SET-in-
FLAG-HA (insensitive to SET siRNA) was constructed based on
pcDNA-SET-FLAG-HA with silent mutations introduced using
the QuikChange kit (Statagene). Primers were: forward primer: 59-
CCAAccacgacggCGCGGATGAAACGTCTGAGaaagaacagc-39;
reverse primer: 59-GCTGTTCTTTCTCAGACGTTTCATC-
CGCGCCGTCGTGGTTGG-39.
pRIAS-Luc, which encodes for single-round (replication-
incompetent) ASV carrying the Luc reporter gene (ASV-Luc),
was built by amplifying Luc sequences from pNLX.Luc(R-) [65]
with primers AE675 (59-GGTACTATCGATAAAGCCAC-
CATGGAAG)/ AE3292 (59-CTAGATCGATTACACGGC-
GATCTTTCC), digesting with Cla I, and ligation to Cla I-
digested pRIAS [66]. siRNAs were transfected using Oligofecta-
mine (Invitrogen) following manufacturer’s protocols. Cells
transfected twice in two consecutive days were infected on the
third day. DNAs were transfected using Lipofectamine 2000
(Invitrogen) following manufacturer’s protocols. siRNAs were
purchased from Dharmacon. Catalog numbers are given for
siRNAs pre-designed by Dharmacon and a single siRNA that gave
the best knockdown from each set of 4 was labeled as ‘preferred’
and used in this study. An equal molar mix of two TREX1 siRNAs
was used to maximize knockdown. All sequences correspond to
sense strand sequence of the target gene.
CD4 siRNA: 59-GAUCAAGAGACUCCUCAGU-39 [67]
SET siRNA: 59-ggccgacgagaccucagaa-39 [24]
NM23-H1 siRNA: 59-GGAUUCCGCCUUGUUGGUC-39
[24]
TREX1 siRNA: #15 9-CCAAGACCATCTGCTGTCA-39;
#25 9-ACAATGGTGACCGCTACGA-39 [23]
BAF-c siRNA: 59-GAAGCUGCACGUAAGGGGU-39 [18]
BAF siRNA: 59-GAAGCUGGAGGAAAGGGG-39 [18]
APE1 siRNA (cat# J-010237): #15 9-CAAAGUUUCUU-
ACGGCAUA-39 (preferred); #25 9-GAGACCAAAUGUU-
CAGAGAUU-39; #35 9-CUUCGAGCCUGGAUUAAGA-
39; #45 9-UAACAGCAUAUGUACCUAA-39
Non-targeting siRNA #1 (cat# D-001210-01): 59-UAGCGA-
CUAAACACAUCAA-39
sh-CTL and sh-APE1 were cloned into pLenti-LOX3.7 using
the following oligos:
sh-CTL: 59-TGTAGCGACTAAACACATCAATTCAAGA-
GATTGATGTGTTTAGTCGCTACTTTTTTC -39 and
59- TCGAGAAAAAAGTAGCGACTAAACACATCAATC-
TCTTGAATTGATGTGTTTAGTCGCTACA -39
sh-APE1:59-TGCAAAGTTTCTTACGGCATATTCAAGA-
GATATGCCGTAAGAAACTTTGCTTTTTTC-39 and 59-
TCGAGAAAAAAGCAAAGTTTCTTACGGCATATCTC-
TTGAATATGCCGTAAGAAACTTTGCA-39.
Integration site sequence analysis
Human (build 36.1, UCSC hg18 release) genomic sequence and
HIV-1NL4-3 sequence databases were used for integration site
sequence analysis, which was done as described [29].
PIC isolation, HIV DNA immunoprecipitation (IP),
antibodies
HIV PICs were isolated as described [29,58] with slight
modifications. Briefly, HeLaCD4 cells grown on 10 cm plates
(80% confluent) were infected with DNase-treated HIV-Luc. Each
plate provided enough cells for two IP experiments. Cells were
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150 mM KCl, 5 mM MgCl2) twice 6 hpi and lysed by rocking
at room temperature for 8 min in 0.5 mL Buffer K+/+ (Buffer
K2/2 containing 16 Protease inhibitors (EDTA-free, Roche),
0.025% digitonin, 1 mM DTT) per 10 cm plate. Supernatants
were obtained following successive centrifugations at 1,5006g for
4 min at 4uC and 15,0006 g for 1 min at 4uC. Resultant
cytoplasmic PIC extracts were incubated with specific antibodies
that were pre-bound to protein A or G agarose beads overnight.
Beads were washed the next morning with 100 mM KCl wash
buffer twice (20 mM Tris7.4, 0.2 mM EDTA, 100 mM KCl,
5 mM ß-mercaptoethanol, 16protease inhibitors complete, 10%
glycerol) and again with the same buffer containing 300 mM KCl
before elution with 26 100 mL 200 mM glycine (pH 3). Eluates
were neutralized by adding 2 mL of 1.5 M Tris-HCl (pH 8.8)
before phenol/chloroform/iodoacetamide extraction and DNA
precipitation. HIV-1 DNA in the IP was quantified using qPCR
with late RT primers (MH531/MH532). Antibodies for IP were:
anti-IN (rabbit, affinity purified) [68], anti-MA (mouse 3H7) [69],
anti-SET (rabbit, affinity purified) [22], anti-NM23-H1 (rabbit,
Santa Cruz #sc343) and anti-LEDGF/p75 (mouse, BD Trans-
duction #611714). Antibodies used for immunoblot were anti-
Ape1 (rabbit, this study), anti-BAF (rabbit, a kind gift of Katherine
Wilson, John Hopkins University School of Medicine) [70].
Quantitative PCR, auto-PCR
HIV-1 late RT, integrated DNA, and 2-LTR circles were
quantified as previously described [29,30]. Briefly, mitochondrial
DNA, late RT and 2-LTR circles in extrachromosomal DNA
fractions were analyzed by qPCR using MIT+/MIT2, MH531/
MH532 and AE2948/AE2949 primers, respectively (sequences
below). b-globin DNA was similarly measured in chromosomal
DNA fractions using b-globin+/b-globin2 primers (sequences
below). Integrated HIV DNA was also measured in chromosomal
fractions, but by Alu-PCR followed by nested qPCR using
AE989/AE990 primers (sequences below). Autointegration prod-
ucts were measured using a two-step nested PCR: Step 1 is a
semiquantitative PCR using 200 ng extrachromosomal DNA, 16
PCR buffer, 1.5 mM MgCl2, 0.2 mM of each primer (PBS2,
NY200/A+, NY199/B2), 0.2 mM of each dNTP and 1.5 U
Platinum Taq polymerase (Invitrogen) in a 25 mL reaction
volume. PCR program was 94uC/5 min, 24 cycles of 95uC/
30 s-60uC/30 s-72uC/3 min, then 72uC/7 min. PCR products
from Step 1 were diluted 1:100 for use in Step 2. Step 2 was a
qPCR assay using AE989/AE990 primers [29]. Autointegration
initiated from the downstream U5 end (Figure S5) was measured
similarly, except for replacing the PBS2 primer with a Luc+
primer (located at the 39 end of the Luc gene, adjacent to the right
LTR).
Primer sequences:
MIT+:5 9-GACGTTAGGTCAAGGTGTAG-39
MIT2:5 9-CAACTAAGCACTCTACTCTC-39
MH531 (late RT forward): 59-TGTGTGCCCGTCT-
GTTGTGT-39
MH532 (late RT reverse): 59-GAGTCCTGCGTCGAGA-
GAGC-39
AE2948 (2-LTR forward): 59-AACTAGGGAACCCACTG-
CTTAAG-39
AE2949 (2-LTR reverse): 59-TCCACAGATCAAGGA-
TATCTTGTC-39
b-globin+:5 9-GAAGAGCCAAGGACAGGTAC-39
b-globin2:5 9-AAGCAATAGATGGCTCTGCC-39
PBS2:5 9-TTTCCGGTCCCTGTTCGGGCGCCA-39
Luc+:5 9-CAAGAAGGGCGGAAAGATCGCCGTGT-39
Alu: 59-TCCCAGCTACTCGGGAGGCTGAGG-39
AE989 (R): 59-TCTGGCTAGCTAGGGAACCCA-39
AE990 (U5): 59-CTGACTAGGATGGTCTGAGG-39
NY199/primer B2:5 9-CTACCTTGTTATGTCCTGC-
TTG-39
NY200/primer A+:5 9-CTCTACAGCACTTGGCAC-
TAGC-39
Supporting Information
Figure S1 Virions released by control and SET/NM23-H1
knockdown cells are equally infectious. Viral supernatants from
control and SET/NM23-H1 knockdown HeLaCD4 cells (24 h
post-HIVIIIB-infection) were normalized for p24 content, and an
equal amount of virons was applied to TZM-bl cells, which are
stably transfected with an LTR-driven Luc reporter gene. Luc
activity was measured 48 hpi.
Found at: doi:10.1371/journal.ppat.1000327.s001 (0.04 MB PDF)
Figure S2 SET knockdown inhibits infection of VSV-G
pseudotyped HIV-Luc across a range of multiplicities of infection
(MOI). HeLa-CD4 cells were transfected first with CTL or SET
siRNA and then 24 h later with vector (V) or SET-in plasmid
DNA. Transfected cells were then infected with indicated MOIs
24 h later and Luc activity was measured 48 h post-infection. *,
p,0.01 relative to control knockdown. Mean and S.D. from two
independent experiments are shown.
Found at: doi:10.1371/journal.ppat.1000327.s002 (0.04 MB PDF)
Figure S3 The consensus sequence for autointegration is
indistinguishable between control and SET/NM23-H1 knock-
down cells. Nucleotide frequency at each position is shown as the
percent of expected frequency if autointegration were random.
Frequencies ,70% (red) or .130% (green) of expected (corre-
sponding to p,0.001) are in bold. The position 0 nucleotide is
joined to the processed U3 end of the LTR. Nucleotide sequences
for positions 0–14 were experimentally determined by sequencing;
those for positions 210 to 21 were assumed from the HIV-Luc
sequence upstream of the mapped integration sites.
Found at: doi:10.1371/journal.ppat.1000327.s003 (0.09 MB PDF)
Figure S4 Detailed diagram of auto-PCR assay. Primers PBS2/
A+ and PBS2/B amplify same-strand and opposite-strand joining
products, respectively, during first-round PCR. The resulting
products contain PBS-LTR (U3RU5) sequences, which are
measured by second-round nested qPCR using R-U5 primers.
Arrowheads, reverse transcript 59 ends; filled circles, 59 phosphates
attacked by the recessed CA-OH ends during autointegration. The
viral DNA ends become joined to these internal sites during CA-
OH attack; the structures in brackets are imaginary intermediates
to aid visualization of reaction pathways. Open circles, internal 39
termini resulting from autointegration.
Found at: doi:10.1371/journal.ppat.1000327.s004 (0.29 MB PDF)
Figure S5 Autointegration from U3 and U5 ends of HIV reverse
transcripts have similar kinetics. (A) A diagram of HIV-Luc reverse
transcripts with auto-PCR primers used. (B,C) Kinetics of
autointegration from U3 (B) and U5 (C) ends. HeLa-CD4 cells
were infected with VSV-G pseudotyped HIV-Luc and extra-
chromsomal DNA was isolated at different times post-infection (as
indicated). The PBS(2) primer binds adjacent to the left long
terminal repeat (LTR), whereas the Luc(+) primer binds adjacent
to the right LTR (the Luc gene replaces nef in the HIV-Luc
The SET Complex Inhibits HIV-1 Autointegration
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used to amplify autointegration events initiated through the U3
end (B), and similarly Luc/A/B primers were used to amplify
autointegration events initiated through the U5 end (C). The same
LTR primers were used in the second-round qPCR.
Found at: doi:10.1371/journal.ppat.1000327.s005 (0.34 MB PDF)
Figure S6 Knocking down BAF does not affect HIV autointe-
gration. (A) Immunoblot demonstrating knockdown of BAF
protein by BAF siRNA but not control siRNA (CTL) or BAF-C
siRNA (which contains three mismatches compared to BAF
siRNA [1]). By densitometry, only 8% of BAF protein remained at
the time cells were infected with HIV-Luc 48 h after transfection.
BAF knockdown inhibited HIV infection about 2-fold as measured
by Luc activity (B), but had no effect on autointegration (C).
Infectivity and autointegration were measured as in Figure 6.
Mean and S.D. of two independent experiments are shown. 1.
Shun MC, Daigle JE, Vandegraaff N, Engelman A (2007) Wild-
type levels of human immunodeficiency virus type 1 infectivity in
the absence of cellular emerin protein. J Virol 81: 166–172.
Found at: doi:10.1371/journal.ppat.1000327.s006 (0.08 MB PDF)
Table S1 Autointegrant sequences recovered from WT and mt
IN viral infections. *Clones that did not contain any viral sequence
are not shown. {The CA dinucleotide at the end of the cleaved U3
minus strand is underlined. {Number refers to position in
reference HIV-1NL4-3 strain.
Found at: doi:10.1371/journal.ppat.1000327.s007 (0.05 MB PDF)
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